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The discovery of antibiotics more than 80 years ago has led to considerable 
improvements in human and animal health. Although antibiotic resistance in 
environmental bacteria is ancient, resistance in human pathogens is thought to be a 
modern phenomenon that is driven by the clinical use of antibiotics1. Here we show 
that particular lineages of methicillin-resistant Staphylococcus aureus—a notorious 
human pathogen—appeared in European hedgehogs in the pre-antibiotic era. 
Subsequently, these lineages spread within the local hedgehog populations and 
between hedgehogs and secondary hosts, including livestock and humans. We also 
demonstrate that the hedgehog dermatophyte Trichophyton erinacei produces two 
β-lactam antibiotics that provide a natural selective environment in which 
methicillin-resistant S. aureus isolates have an advantage over susceptible isolates. 
Together, these results suggest that methicillin resistance emerged in the 
pre-antibiotic era as a co-evolutionary adaptation of S. aureus to the colonization of 
dermatophyte-infected hedgehogs. The evolution of clinically relevant 
antibiotic-resistance genes in wild animals and the connectivity of natural, 
agricultural and human ecosystems demonstrate that the use of a One Health 
approach is critical for our understanding and management of antibiotic resistance, 
which is one of the biggest threats to global health, food security and development.
Methicillin-resistant S. aureus (MRSA) is one of the most common 
antibiotic-resistant bacterial pathogens, causing approximately 
171,000 invasive infections each year in Europe alone2. MRSA was 
first identified in 1960 shortly after the introduction of methicillin 
(celbenin) as a treatment option against penicillin-resistant S. aureus 
clones3, but was possibly selected for by the clinical use of penicillin 
over the previous 20 years4. Methicillin resistance has subsequently 
emerged in many S. aureus clones around the world, both in hospital 
and community settings as well as in livestock such as pigs and cattle5,6. 
This has serious implications for the treatment of severe infections and 
the World Health Organization now considers MRSA to be an important 
threat to human health7.
Methicillin resistance in S. aureus is mediated by the mecA and mecC 
genes, which encode the enzymes penicillin-binding protein 2a (PBP2a) 
and PBP2c, respectively. mecA and mecC confer resistance to almost all 
β-lactam antibiotics, including penicillinase-labile penicillins (such as 
penicillin G), penicillinase-stable penicillins (such as methicillin) and 
cephalosporins (such as cefoxitin).
Hedgehog surveys from Denmark and Sweden demonstrated a 
surprisingly high prevalence of MRSA carrying mecC (mecC-MRSA)8,9, 
raising the possibility that the evolution of these bacteria was 
driven by natural selection in wildlife, as opposed to clinical use of 
antibiotics. Historically, mecC-MRSA was first discovered in dairy 
cows and subsequently in humans10, suggesting that the use of 
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antibiotics in livestock was providing a selective advantage and that 
human infections were the result of zoonotic transmission. Studies 
from many different European countries revealed that mecC-MRSA 
is also present in other domesticated animals such as sheep, goats 
and horses as well as in a broad range of wild animals, albeit at low 
frequencies11.
Our hypothesis that the evolution of mecC-MRSA was driven 
by natural selection is supported by studies from northwestern 
Europe and New Zealand that showed that hedgehogs are frequently 
colonized with the dermatophyte T. erinacei, which produces a 
penicillinase-labile penicillin-like substance that was recently iden-
tified as penicillin G12–19. To test our hypothesis, we examined the 
distribution of mecC-MRSA and other S. aureus isolates in hedge-
hogs in ten European countries and New Zealand. We sequenced 244 
S. aureus isolates from hedgehogs and 913 S. aureus isolates from 
other sources to infer the evolutionary histories, host dynamics, 
geographical dispersal patterns and zoonotic potential of the major 
mecC-MRSA clones in Europe. The potential mechanisms for the natu-
ral selection of mecC-MRSA by T. erinacei were assessed by analysing 
the genome of T. erinacei for β-lactam biosynthetic genes and by 
screening T. erinacei for the production of β-lactams and antibiotic 
activity against a panel of S. aureus strains.
The distribution of mecC-MRSA in hedgehogs
We first examined the geographical distribution and population 
structure of mecC-MRSA in European hedgehogs, which inhabit large 
parts of Europe as a result of postglacial expansion from Pleistocene 
refugia20. European hedgehogs have also become widespread in New 
Zealand after a series of introductions from the UK between 1869 and 
1892 (ref. 21). We analysed 828 samples from the nasal area, skin and 
feet of 276 hedgehogs originating from 16 wildlife rescue centres in 
10 European countries and 2 wildlife rescue centres in New Zealand 
(Fig. 1 and Extended Data Fig. 1). mecC-MRSA was present in 101 of 
the 172 hedgehogs (222 out of 516 samples) from England and Wales 
(66%, 81 out of 123), Czech Republic (50%, 6 out of 12), Denmark (50%, 
11 out of 22), Portugal (29%, 2 out of 7) and New Zealand (6%, 1 out 
of 17), therefore extending the known geographical distribution of 
mecC-MRSA in hedgehogs (Fig. 1 and Extended Data Fig. 1). By contrast, 
all 104 hedgehogs (312 samples) from Greece, Romania, Italy, France 
and Spain tested negative for mecC-MRSA. Whole-genome sequenc-
ing showed that the 222 mecC-MRSA isolates belonged to 6 clonal 
complexes, CC130 (75%), CC1943 (15%), CC2616 (6%), CC425 (3%), 
CC49 (1%) and CC599 (1%), of which CC130 had the most widespread 
distribution across western and central Europe (Fig. 1 and Extended 
Data Fig. 1). We screened all of the MRSA-negative hedgehog samples 
from our study (n = 606) for the presence of methicillin-susceptible 
S. aureus (MSSA) isolates belonging to the same clonal complexes as 
the mecC-MRSA isolates (Extended Data Fig. 1). This led to the iden-
tification of 22 MSSA isolates, including 13 CC49 isolates from Spain 
(n = 9), Denmark (n = 3) and Portugal (n = 1), and 9 CC130 isolates from 
England (n = 8) and Spain (n = 1).
The mecC gene encoding PBP2c is located immediately upstream 
of a blaZ gene (hereafter, blaZLGA251) on a chromosomally integrated 
mobile genetic element known as a type XI staphylococcal cassette 
chromosome mec (SCCmec). PBP2c and the blaZLGA251-encoded peni-
cillinase are orthologues of the PBP2a enzyme and penicillinase pro-
duced by other S. aureus clones, although they share only 63% and 65% 
amino acid identities with each other, respectively10. Penicillinases 
have a narrower spectrum than PBP2a and PBP2c and provide resist-
ance only to penicillin G and other penicillinase-labile subclasses of 
penicillin. As expected, blaZLGA251 was present in the 222 mecC-MRSA 
isolates but absent in the 22 MSSA isolates. However, 14 of the MSSA 
isolates carried the blaZ gene found in other S. aureus clones (Sup-
plementary Table 1).
Production of β-lactams by T. erinacei
The abundance of mecC-MRSA in hedgehogs led us to speculate that 
antibiotic production by T. erinacei provides a selective environment 
in which mecC-MRSA isolates have an advantage over susceptible iso-
lates. Genome sequencing and analysis of the T. erinacei type strain 
IMI 101051 (ATCC 28443) identified orthologues of pcbAB, pcbC and 
penDE, which are responsible for key steps in penicillin G production 
by Penicillium chrysogenum, as well as the Acremonium chrysogenum 
early cephalosporin C biosynthetic genes cefD1 and cefD2, which are 
involved in the conversion of isopenicillin N into penicillin N (Fig. 2 and 
Extended Data Table 1). By contrast, T. erinacei IMI 101051 lacked the A. 
chrysogenum late cephalosporin C biosynthetic genes cefEF and cefG. 
P. chrysogenum also carries cefD1 and cefD2 but is nevertheless incapa-
ble of producing cephalosporins due to the lack of cefEF and cefG22,23.
We processed four distinct culture broths of T. erinacei IMI 101051 for 
metabolic profiling using liquid chromatography–mass spectrometry 
(LC–MS) and molecular networking analysis. This led to the identifica-
tion of two β-lactams, penicillin G and 6-(5-hydroxy-n-valeramido)-pe
nicillanic acid (KPN), both of which belong to the penicillin class of 
antibiotics (Extended Data Figs. 2 and 3 and Supplementary Fig. 1). 
KPN has to date been found only in culture broths of fungal strains 
belonging to the genus Paecilomyces24 and differs from penicillin G 
by having a unique side chain (Extended Data Figs. 2 and 3 and Supple-


























Fig. 1 | Distribution of mecC-MRSA clones in European and New Zealand 
hedgehog samples. The analysis included 828 samples from the nasal area, 
skin and feet of 276 hedgehogs originating from 16 wildlife rescue centres in  
10 European countries and 2 wildlife rescue centres in New Zealand. The red 
dots indicate the sampling locations. The pie charts are connected to the 
sampling locations by a red line. The area of the pie chart is proportional to the 
number of samples from that location. The introduction of European 
hedgehogs into New Zealand from the UK between 1869 and 1892 is shown.  
A detailed description of the results is provided in Extended Data Fig. 1. Maps 
were provided by Eurostat under a Creative Commons Attribution 4.0 
International (CC BY 4.0) licence; the administrative boundaries are copyright 
of EuroGeographics.
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Selection of mecC-MRSA by T. erinacei
Four culture broths of T. erinacei IMI 101051 were screened for 
antibiotic activity against a collection of S. aureus control strains. 
All of the culture broths produced large inhibition zones against 
two penicillin-susceptible S. aureus strains—ATCC 9144 (Oxford 
S. aureus) and ATCC 25923—but much smaller zones against the 
penicillinase-producing S. aureus strain ATCC 29213 and the 
mecA-positive S. aureus strain ATCC 43300 (Fig. 2 and Extended 
Data Fig. 4). The role of mecC and blaZLGA251 was assessed by screen-
ing the culture broths for antibiotic activity against two mecC-MRSA 
wild-type strains belonging to CC130 (02.5099.D) and CC425 (LGA251) 
and their isogenic mutants. The mutants with deleted mecC (ΔmecC), 
blaZLGA251 (ΔblaZLGA251), and mecC and blaZLGA251 (ΔmecC-blaZLGA251) pro-
duced significantly larger inhibition zones compared with the corre-
sponding wild-type strains, although the zones of the ΔblaZLGA251 and 
ΔmecC-blaZLGA251 mutants were larger compared with the zones of the 
ΔmecC mutants (Fig. 2 and Extended Data Fig. 4). These results indicate 
that mecC and blaZLGA251 both contribute to the reduced susceptibility 
of mecC-MRSA to penicillin G and KPN present in culture broths of 
T. erinacei IMI 101051.
Evolutionary history of mecC-MRSA
We sought to infer the evolutionary histories of S. aureus CC130, CC425 
and CC1943, which constitute the most successful mecC-MRSA clones 
in Europe10,11,25. For this purpose, we collected and sequenced 786 
mecC-MRSA and 127 MSSA CC130, CC425 and CC1943 isolates selected 
to represent the known geographical distribution (mainly western and 
central Europe) and host repertoire (mainly humans, cattle, sheep, 
goats and wild animals) of each clone (Supplementary Table 1). We used 
core-genome single-nucleotide polymorphism (SNP) diversity and isola-
tion dates to infer time-scaled phylogenies of these isolates and the 205 
mecC-MRSA and 9 MSSA CC130, CC425 and CC1943 isolates collected 
from hedgehogs (Supplementary Table 1). The sequencing data were 
processed for pan-genome analysis to identify antibiotic-resistance 
genes (ARGs) and mobile genetic elements that encode human- and 
ruminant-specific immune modulators that are involved in host switch-
ing events, including a phage-encoded immune evasion cluster-1 (IEC-1) 
enabling S. aureus to evade the human innate immune response and a 
staphylococcal pathogenicity island (SaPI)-encoded vwb gene (vwbSaPI), 
which encodes a von Willebrand factor-binding protein with coagulase 
activity against ruminant plasma26.
We also sought to infer a time-scaled phylogeny of the 991 type XI 
SCCmec elements containing the mecC and blaZLGA251 genes but the 
correlation between root-to-tip distances and isolation dates was too 
weak with a coefficient of determination R2 = −0.05 (Extended Data 
Fig. 5). Instead, we used the topology of the type XI SCCmec phylogeny 
to identify monophyletic mecC-MRSA lineages harbouring ortholo-
gous type XI SCCmec elements. The type XI SCCmec elements could 
be traced back to seven nodes that were connected to each other on 
a long backbone. Each of the backbone nodes and its orthologous 
descendants received the same letter designation to reflect their 
genetic relationship (A to G) (Fig. 3 and Supplementary Fig. 2). Manual 
mapping of the tips onto the CC130, CC425 and CC1943 phylogenies, 
and vice versa, enabled us to assign the mecC-MRSA isolates to 16 
monophyletic lineages harbouring orthologous type XI SCCmec 
elements (Fig. 3 and Supplementary Figs. 2–5). The 129 mecC-MRSA 
CC1943 isolates could be divided into three lineages (C1 to C3), 
which probably originated in the early-to-late 1800s, long before the 
first β-lactam—penicillin G—became widely available as a therapeu-
tic option in the 1940s (Fig. 3). The 786 mecC-MRSA CC130 isolates 
and 76 mecC-MRSA CC425 isolates belonged to 10 and 3 lineages 
(A1 to A10 and B1 to B3, respectively) (Fig. 3). Several of these lineages 
also originated in the pre-antibiotic era (Fig. 3). Most mecC-MRSA 
isolates lacked vwbSaPI (96%, 949 out of 991) and IEC-1 (100%, 990 out 
of 991) and were genotypically susceptible to non-β-lactam antibiot-
ics (Supplementary Figs. 3–5). The largest mecC-MRSA CC425 lineage 
(CC425:B3) had a unique evolutionary trajectory with signs of adap-
tation to ruminants (Supplementary Fig. 4). The basal mecC-MRSA 
CC425:B3 isolates probably originated in England during the early 
1940s and shared epidemiological and genetic characteristics with the 
other mecC-MRSA lineages: they were associated with multiple hosts, 
including hedgehogs, cattle and humans, and lacked vwbSaPI and IEC-1. 
By contrast, their descendants (CC425:B3.1) harboured vwbSaPI, were 
restricted to cattle and humans in southwest England and probably 
diverged during the 1960s (date of the most recent common ancestor 
(MRCA), 1965; 95% confidence interval (CI), 1926–1986). Our analysis 
revealed that some of the mecC-MRSA lineages (CC130:A2, CC425:B3 
and CC1943:C1) carried unique variants of the type XI SCCmec element, 
supporting that they have evolved through vertical inheritance from 
the MRCA of each mecC-MRSA lineage, whereas others shared the same 
type XI SCCmec variant (Fig. 3 and Supplementary Figs. 2–5). The latter 
findings could be the result of either purifying (negative) selection, 
convergent evolution, homologous recombination between different 
mecC-MRSA lineages or horizontal gene transfer.
To better understand the potential role of horizontal gene transfer 
in the evolution of the three early mecC-MRSA CC1943 lineages, we 
determined the smallest number of sublineages that were present at 
a given time point, which is also the smallest number of acquisition 
events that could explain the presence of the same type XI SCCmec 
variant in all sublineages (Extended Data Fig. 6). The analysis showed 
that mecC-MRSA CC1943 consisted of 15 sublineages in 1940, just 
before penicillin G became available as a therapeutic option. It has 
previously been estimated that SCCmec was acquired in a single 
horizontal gene transfer event in three of the major hospital- and 
community-associated MRSA clones4,27,28, although multiple introduc-
tions have also been reported29. Thus, it is more plausible to assume 
that the type XI SCCmec element was present in the MRCA of each 
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Fig. 2 | Penicillin biosynthetic genes and antibiotic activity of T. erinacei IMI 
101051. a, Schematic of the key steps in the biosynthesis of penicillin G and 
cephalosporin C. The presence (green) or absence (red) of T. erinacei penicillin 
G and cephalosporin C biosynthetic genes is indicated. b, T. erinacei inhibition 
zones against a collection of S. aureus control strains (black) and two 
mecC-MRSA wild-type strains belonging to CC130 (green) and CC425 (blue) and 
their isogenic mutants. Two-tailed paired Student’s t-tests were used to 
compare inhibition zones of each mutant to the corresponding wild-type strain. 
Data are mean ± s.d.; n = 4 biologically independent fungal culture extracts.  
A detailed description of the results is provided in Extended Data Fig. 4.
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mecC-MRSA CC1943 lineage rather than assuming horizontal gene 
transfer into each of the 15 sublineages within a few years at the begin-
ning of the antibiotic era. Vertical inheritance of the type XI SCCmec 
element is also consistent with the apparent absence of admixture 
between the different mecC-MRSA CC1943 lineages despite the fact 
that they are often found in hedgehogs within the same geographical 
area (Extended Data Fig. 7). Notably, the type XI SCCmec variants found 
in mecC-MRSA CC1943:C2 (E) and CC1943:C3 (F) were each other’s 
neighbours on the type XI SCCmec phylogeny, and it is therefore pos-
sible that the type XI SCCmec element was acquired even earlier (date 
of the MRCA, 1737; 95% CI, 1562–1824).
MSSA isolates comprised 8% (67 out of 851), 47% (68 out of 144) and 
0.8% (1 out of 130) of the CC130, CC425 and CC1943 isolates, respec-
tively. The vast majority of the MSSA CC130 and MSSA CC425 isolates, 
but not the single MSSA CC1943 isolate, were basal to the correspond-
ing mecC-MRSA lineages (Supplementary Figs. 3–5). Most of the basal 
MSSA CC130 isolates originated from sheep and goats in Italy, France, 
Spain and Norway and harboured vwbSaPI. Moreover, some of the iso-
lates carried ARGs against antibiotics that are used to treat infections 
in sheep and goats, including the two tetracycline-resistance genes 
tet(K) and tet(L), the blaZ gene found in other S. aureus clones, the 
chloramphenicol resistance gene cat and the macrolide resistance 
gene erm(C). The earliest branching CC425 lineages were epidemio-
logically and genetically diverse with respect to host range and the 
presence/absence of the type XI SCCmec element, vwbSaPI and ARGs, 
although most originated from wild animals in Spain and lacked the 
aforementioned genetic determinants. Together, these findings sug-
gest that CC130 and CC425 emerged from distinct ruminant and wild-
life reservoirs in Europe and that methicillin resistance is an acquired 
phenotype within these clones.
Population dynamics of mecC-MRSA
Hedgehogs constitute a large reservoir of mecC-MRSA clones, as dem-
onstrated here and elsewhere8,9, whereas mecC-MRSA isolates are pre-
sent at much lower frequencies in humans, domesticated animals and 
other wild animals. Hedgehog isolates were present in 9 out of the 16 
mecC-MRSA lineages, including the 8 largest (≥25 isolates) and 3 earliest 
(200–130 years ago) lineages (Fig. 3). The 2 largest mecC-MRSA CC130 lin-
eages (CC130:A9 and CC130:A10) encompassed 67% (232 out of 344), 65% 
(339 out of 520) and 43% (66 out of 153) of all mecC-MRSA isolates from 
hedgehogs, humans and other sources, respectively, and had the broad-
est geographical ranges in western and central Europe (Extended Data 
Fig. 7 and Supplementary Figs. 3–5). Several of the major mecC-MRSA 
CC130 and CC1943 lineages (such as CC130:A9, CC130:A10, CC1943:C1, 
CC1943:C2 and CC1943:C3) contained isolates that were separated by 
wide expanses of seawater, reflecting numerous long-distance disper-
sal events between British and Danish islands and mainland Europe 
within the past 200 years (Extended Data Fig. 7 and Supplementary 
Figs. 3–5). By contrast, analysis of the fine-scale population structure 
of mecC-MRSA isolates from hedgehogs revealed a detailed pattern of 
diversifications over short distances, resulting in substantial concord-
ance between genetic clusters and geography at the local level (Supple-
mentary Figs. 3–5). The observed clustering is consistent with the limited 
dispersal capacity of hedgehogs and the effects of habitat fragmentation.
Assuming that hedgehogs act as local reservoirs (sources) of 
mecC-MRSA in Denmark, theoretical considerations predict that sec-
ondary transmission to other hosts (sinks) would lead to similar patterns 
of genetic variation within these secondary hosts cohabiting the same 
geographical region. To examine this theory, we determined the local 
population structures of two broad collections of Danish mecC-MRSA 
isolates from hedgehogs and humans covering the geographical ranges 
of two of the three Danish hedgehog subpopulations, namely Jutland 
(a peninsula connected to continental Europe) and major islands30. 
Hedgehog and human isolates from the geographical range of the 
remaining hedgehog subpopulation (the small island of Bornholm) were 
excluded from the analysis due to their small sample size (nine isolates). 
Most of the CC130:A10 isolates from Jutland formed a distinct subline-
age (CC130:A10.1) together with isolates from other parts of Europe 
(Supplementary Fig. 3). As a consequence, CC130:A10.1 isolates were 
treated as a separate group in the analysis. The results revealed dis-
tinct patterns of regional dispersal with little overlap between Jutland 
and the major islands and a notable correlation between the popula-
tion structures of hedgehog and human isolates at the regional level 
(P = 0.0149, two-sided Wilcoxon matched-pairs signed-rank test) (Fig. 4 
and Extended Data Fig. 8). These findings support the hypothesis that 
human isolates originate from local hedgehog reservoirs, although it 
should be noted that the data presented here do not provide evidence 
for directionality or rule out the involvement of other animal reservoirs 
(such as livestock) as part of the transmission chains.
Discussion
This research shows that hedgehogs are a natural reservoir of zoonotic 
mecC-MRSA lineages that predate the antibiotic era, which is inconsist-
ent with the commonly accepted view that widespread resistance in 
clinical pathogens is a modern phenomenon that is driven by our use 
of antibiotics in human and veterinary medicine.
Data on the prevalence of mecC-MRSA in humans and different animal 





















































































Fig. 3 | Timeline of mecC-MRSA CC130, CC425 and CC1943 evolution in 
Europe. Manual mapping of the tips on the type XI SCCmec phylogeny onto 
the CC130, CC425 and CC1943 phylogenies, and vice versa, enabled us to 
assign the mecC-MRSA isolates to 16 monophyletic lineages containing 
orthologous type XI SCCmec elements (A–G). The trees are redrawn from 
Supplementary Figs. 2–5 to illustrate the branching order of the different type 
XI SCCmec variants and mecC-MRSA lineages. Branch lengths are not drawn to 
scale. The presence and absence of hedgehog isolates in a given lineage are 
shown as black and white boxes, respectively. A detailed description of the 
geographical distribution and host range of major mecC-MRSA CC130, CC425 
and CC1943 lineages is provided in Extended Data Fig. 7. The estimated date of 
the most recent common ancestor and 95% confidence interval of each 
mecC-MRSA lineage are illustrated by filled circles and horizontal lines, 
respectively. The introduction of penicillin G and methicillin as therapeutic 
options is indicated by red lines.
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some countries. For example, in Denmark, the prevalence in hedgehogs 
is considerably higher than in cattle (veal calves and bulk tank milk), 
sheep and goats (61% versus 0.0–1.1%)8,31,32, and the number of human 
cases is relatively low (3–36 cases per year)25. This is further supported 
by our finding that mecC-MRSA generally lacks genetic markers of 
human and ruminant adaptation, with the notable exception of the 
CC425:B3.1 lineage that has undergone a host jump from hedgehogs to 
cattle in southwest England. Before this study, dairy cows were consid-
ered to be the most likely reservoir of mecC-MRSA and a major source 
of zoonotic infections in humans. This hypothesis was supported by 
the fact that β-lactams are commonly used to treat bovine mastitis, 
as shown by sales data from Denmark and the UK33,34. However, our 
findings strongly suggest that most mecC-MRSA lineages originate 
from hedgehogs, although dairy cows and other domesticated animals 
probably act as intermediate hosts and vectors in zoonotic transmission 
from hedgehogs to humans, as previously demonstrated35.
Here we show that the T. erinacei type strain IMI 101051 from New 
Zealand produces two β-lactams—penicillin G and KPN—and that 
mecC and blaZLGA251 both contribute to reduced susceptibility of 
mecC-MRSA to these antibiotics. Previous studies have established 
that T. erinacei is widespread among hedgehogs in New Zealand and 
northwestern Europe and that isolates from both continents pro-
duce a penicillinase-labile penicillin-like substance12–19, and a recent 
study characterized penicillin G from T. erinacei in Sweden (the pres-
ence of other β-lactams was not investigated)19. This suggests that 
penicillin-producing T. erinacei isolates were circulating in European 
hedgehogs long before they were introduced into New Zealand in the 
late 1800s and that methicillin resistance first emerged in Europe as a 
co-evolutionary adaptation of S. aureus to colonization of hedgehogs. 
By contrast, it cannot be ruled out that clinical use of antibiotics in 
humans and livestock has contributed to the evolution of some of the 
younger mecC-MRSA CC130 and CC425 lineages, although only one of 
these lineages (CC425:B3) showed signs of adaptation to either of these 
hosts. Our findings indicate that seven of the younger mecC-MRSA line-
ages (CC130:A3, CC130:A4, CC130:A5, CC130:A6, CC130:A8, CC130:A9 
and CC425:B1) have acquired their type XI SCCmec variants from the 
early mecC-MRSA CC1943:C2 and CC1943:C3 lineages (Fig. 3 and Sup-
plementary Figs. 2–5). The type XI SCCmec element has also been found 
at low frequencies in coagulase-negative Staphylococcus species from 
wild animals and livestock but the evolutionary links between these 
potential donors and mecC-MRSA remain to be investigated36.
Our analyses suggest that most mecC-MRSA transmission events 
within hedgehog populations and between hedgehogs and secondary 
hosts are highly localized. The finding that some human mecC-MRSA 
isolates probably originate from local hedgehog reservoirs indicates 
that mecC-MRSA has been a cause of sporadic infections in humans for 
the past 200 years, more than a century before MRSA was first identified 
in patients in 1960 (ref. 3). The host interactions that lead to zoonotic 
transmission probably include direct contact with hedgehogs or contact 
with secondary animal hosts such as dairy cows, as previously shown for 
T. erinacei (the cause of ‘hedgehog ringworm’ in humans)13. We also iden-
tified several long-distance dispersal events between British and Danish 
islands and mainland Europe. The connections that bridge geographi-
cally isolated hedgehog populations are poorly understood but might 
involve oversea movements of humans and livestock. Furthermore, a 
recent report of mecC-MRSA in white storks raises the possibility that 
migratory birds could be efficient long-distance carriers37.
β-Lactams target PBPs that catalyse carboxypeptidase and trans-
peptidase reactions during bacterial cell wall synthesis, whereby they 
inhibit cross-linking of neighbouring peptidoglycan strands. The pri-
mary mechanisms of β-lactam resistance in S. aureus are enzymatic 
cleavage of the amide bond in the β-lactam ring of penicillinase-labile 
penicillins by blaZ-encoded penicillinases and the production of mecA- 
or mecC-encoded PBP2a and PBP2c, respectively, with a decreased 
affinity for a broad spectrum of β-lactams. Our findings support that 
both mechanisms contribute to protection against penicillin produc-
tion by T. erinacei in hedgehogs, although it should be noted that the 
ΔmecC mutants produced smaller inhibition zones than the ΔblaZLGA251 
mutants. This might be due to the fact that PBP2c has a relatively high 
binding affinity for penicillins compared with PBP2a38. It is also possible 
that PBP2c provides additional ecological benefits, such as protec-
tion against cephalosporin-producing fungi and bacteria that occur 
naturally in all environments39.
mecC and blaZLGA251 have also been found on a pseudo-SCCmec ele-
ment (ΨSCCmecP5085) in Staphylococcus edaphicus, a soil-dwelling 
bacterial species isolated from Antarctica40. In contrast to the type 
XI SCCmec element, ΨSCCmecP5085 lacks the cassette chromosome 
recombinase (ccr) genes that are responsible for movement (excision 
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Fig. 4 | Population structures of Danish mecC-MRSA isolates from 
hedgehogs and humans. a, The map of Denmark shows the geographical 
ranges of two of the three hedgehog subpopulations in Jutland and on the 
major islands. b, The geographical distribution of major mecC-MRSA CC130, 
CC425 and CC1943 lineages in two broad collections of mecC-MRSA isolates 
recovered from hedgehogs (n = 141) and humans (n = 327) in Jutland and on the 
major islands. Hedgehog and human isolates from the remaining hedgehog 
subpopulation on the small island of Bornholm (not shown) were excluded 
from the analysis due to their small sample size (n = 9). A detailed map of the 
sampling locations is provided in Extended Data Fig. 8. Maps were provided by 
Eurostat under a Creative Commons Attribution 4.0 International (CC BY 4.0) 
licence; the administrative boundaries are copyright of EuroGeographics.
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ancient and modern samples and bacteria from natural environment 
such as soil41–43. Yet, the environmental resistome shows limited poten-
tial for horizontal gene transfer and, for this reason, the contribution of 
environmental ARGs to resistance in human pathogens has so far been 
controversial44. It seems reasonable to assume that the microbiota of 
wild animals have greater exposure to the environmental resistome 
than the human microbiota and are therefore more likely to acquire 
environmental ARGs. Thus, wild animals might represent a hitherto 
unrecognized conduit through which environmental ARGs can be 
transferred to clinical pathogens.
We acknowledge some limitations of our study. Although we 
broadly sampled hedgehogs across Europe and New Zealand, our 
study represents only a small part of the geographical range and 
a small number of hedgehog samples in most countries. Thus, the 
distribution and diversity of mecC-MRSA in Europe and New Zealand 
might be larger than documented here. We cannot account for the 
potential effect of transmission within the different wildlife rescue 
centres. To better understand the transmission dynamics, we exam-
ined the frequency of potential transmission events of mecC-MRSA 
CC130 within the different facilities using a range of maximum 
pairwise SNP distance thresholds to define a cluster (Extended 
Data Fig. 9). Using a conservative cut-off of 25 SNPs (transmission 
age < 6 months)45, 25% (683 out of 2,783) of the mecC-MRSA CC130 
isolate pairs collected within the same facility belonged to a potential 
transmission cluster. It is therefore possible that the prevalence of 
mecC-MRSA in hedgehogs kept in such facilities is higher than in 
the wild, although it is also probable that some of these potential 
transmission events occurred in the wild before admission to the 
facility. Notably, a previous study found that there is only a slightly 
lower prevalence of mecC-MRSA in hedgehogs that died in the wild 
compared with hedgehogs that died while staying in a wildlife rescue 
centre8, which is consistent with our finding that most hedgehogs 
acquired mecC-MRSA outside the facility. We were unable to test the 
hedgehogs for carriage of T. erinacei, because ethical constraints 
precluded us from collecting appropriate tissues (skin scrapings, 
hair and spines) for fungal culture, which leaves some important 
questions unanswered. For example, it remains unclear whether 
penicillin-producing T. erinacei isolates are present throughout 
Europe and whether there is a link between their distribution and 
the geographical range of mecC-MRSA.
In conclusion, we describe the ecological and evolutionary mech-
anisms that led to the emergence of methicillin resistance in the 
pre-antibiotic era, possibly as a co-evolutionary adaptation of S. aureus 
to colonization of dermatophyte-infected hedgehogs. These results 
underscore the importance of taking a broad One Health perspective on 
antibiotic resistance that recognises the role of natural selection in wild 
animals and the connectivity of natural, agricultural and human eco-
systems in the evolution and spread of antibiotic-resistant pathogens.
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The aim was to collect hedgehog samples covering the geographical 
range of hedgehogs in Europe and New Zealand. Personnel at 16 wild-
life rescue centres in ten European countries and two wildlife rescue 
centres in New Zealand were instructed to obtain samples from the 
nasal area, skin and feet of hedgehogs kept in separate enclosures using 
FLOQSwabs (Copan). Swabs were stored in liquid Amies medium at 
ambient temperature and sent to the National Reference Laboratory for 
Antimicrobial Resistance at Statens Serum Institut in Denmark or the 
Department of Veterinary Medicine at University of Cambridge in the 
UK immediately after sample collection. For each swab, a loopful (10 µl) 
of liquid Amies was inoculated into 5 ml Mueller–Hinton broth (Oxoid) 
supplemented with 6.5% NaCl and incubated overnight at 35–37 °C. A 
loopful (10 µl) of enrichment broth was then streaked on a Brilliance 
MRSA 2 (Oxoid) agar plate followed by incubation at 35–37 °C for 24 h. 
One presumptive MRSA colony from each plate was subcultured on a 
blood agar plate at 35–37 °C for 24 h and archived at −80 °C. We also 
screened all MRSA-negative samples for the presence of MSSA iso-
lates by streaking a loopful (10 µl) of enrichment broth on a SaSelect 
(Bio-Rad) and Brilliance Staph 24 (Oxoid) agar plate followed by incu-
bation at 35–37 °C for 24 h. One presumptive S. aureus colony from 
each plate was subcultured on a blood agar plate at 35–37 °C for 24 h 
and archived at −80 °C.
The hedgehog survey was conducted by staff members of the wildlife 
rescue centres who collected swab samples in connection with routine 
checks. In accordance with the Animal Welfare Act 1999 administered by 
the New Zealand Ministry for Primary Industries and Directive 2010/63/EU 
of the European Parliament and of the Council of 22 September 2010 
on the protection of animals used for scientific purposes, no ethi-
cal approval was required as sample collection did not cause pain, 
suffering, distress or lasting harm equivalent to, or higher than, that 
caused by the introduction of a needle in accordance with good veteri-
nary practice or deprived the animal of usual care. Ethical review was 
undertaken at the Department of Veterinary Medicine, University of 
Cambridge (CR76).
Bacterial isolates and whole-genome sequencing
A list of the 1,157 isolates used in this study is provided in Supplementary 
Table 1, including all of the mecC-MRSA (n = 222) and MSSA (n = 22) 
isolates identified in the hedgehog survey described above and an 
European collection of mecC-MRSA (n = 786) and MSSA (n = 127) iso-
lates belonging to CC130, CC425 and CC1943, which constitute the 
most successful mecC-MRSA clones in Europe10,11,25. Most of the Danish 
isolates originated from two nationwide collections of mecC-MRSA 
and MSSA isolates recovered from hedgehogs and humans. The Dan-
ish collection of hedgehog isolates included 114 mecC-MRSA isolates 
collected from 188 hedgehogs in a previous study8. We re-examined the 
74 MRSA-negative hedgehog samples for the presence of MSSA isolates 
using the method described above, which led to the inclusion of two 
MSSA isolates belonging to CC130 (n = 1) and CC425 (n = 1) as well as six 
mecC-MRSA isolates belonging to CC130 (n = 3) and CC1943 (n = 3) that 
were missed in the original screening. The Danish collection of human 
isolates comprised 334 mecC-MRSA and 2 MSSA isolates that were col-
lected from colonized or infected individuals between 1975 and 2016 
as part of the national MRSA and S. aureus bacteraemia surveillance 
programmes. The remaining CC130, CC425 and CC1943 isolates were 
selected to represent the known geographical distribution (mainly 
western and central Europe) and host repertoire (mainly humans, 
cattle, sheep, goats and wild animals) of each clone. Whole-genome 
sequencing of the 1,157 isolates was performed on different Illumina 
platforms at the Wellcome Sanger Institute or at Statens Serum Institut. 
Short-read sequence data are available in the European Nucleotide 
Archive/NCBI Sequence Read Archive under BioProject IDs PRJEB15105, 
PRJEB21015, PRJEB2655, PRJEB2755, PRJEB2756, PRJEB28206, PRJEB3174, 
PRJEB32898, PRJNA596428 and PRJEB43456 and the genome accession 
numbers are provided in Supplementary Table 1.
Sequence analyses
Draft genomes were de novo assembled using SPAdes (v.3.15)46. Multi-
locus sequence typing (MLST) was performed by comparing the draft 
genomes with the S. aureus MLST database47. We used the scn gene 
(which encodes staphylococcal complement inhibitor-A and an indi-
cator of the IEC-1 element48) in S. aureus strain Newman (GenBank: 
NC_009641) and the vwbSaPI gene in SaPIbov4 (GenBank: HM211303) as 
queries in BLASTN searches against the draft genomes, setting length 
match to 0.9 and similarity match to 0.7. These parameters were chosen 
to account for allelic diversity of the vwb genes located on SaPIs (shar-
ing 76–100% nucleotide identities with each other)49 while effectively 
excluding scn homologues located outside the IEC-1 element (sharing 
48–61% nucleotide identities with scn)50. Contigs with hits for vwb were 
analysed using PHASTER51 to ascertain that they were located on SaPIs. 
ARGs were detected by mapping sequence reads against the ResFinder 
database52 using the k-mer alignment (KMA) tool (v.1.3)53, setting both 
length match and similarity match to 0.9.
Phylogenetic analyses of S. aureus CC130, CC425 and CC1943
All 991 mecC-MRSA and 136 MSSA isolates belonging to CC130, CC425 
and CC1943 were included. Mapping of sequence reads and SNP calling 
were performed using NASP (v.1.0)54 as follows: (1) sequence reads were 
mapped against the reference genome of mecC-MRSA CC425 isolate 
LGA251 (GenBank: NC_017349) with the Burrows–Wheeler Alignment 
tool55; (2) SNP calling was achieved using the GATK Unified Geno-
typer56,57, setting depth of coverage and unambiguously base calls to 
≥10× and ≥90%, respectively, and ignoring insertions and deletions; 
and (3) SNPs contained in repeats were excluded using NUCmer58,59.
Unrooted maximum-likelihood phylogenetic trees were built from 
core-genome SNP alignments with PhyML (v.3.0)60,61 under the HKY85 
substitution model after applying NNI moves to improve the BIONJ 
starting tree. Putative recombinogenic regions were detected and a 
recombination-corrected phylogeny was built with ClonalFrameML 
(v.1.12)62. Time-resolved phylogenies, in which the date of each node is 
estimated, were constructed with BactDating (v.1.0)63 using an additive 
uncorrelated relaxed clock model64. Convergence and mixing of the 
Markov Chain Monte Carlo chains were determined using the R pack-
age coda65. The time-resolved phylogenies were rooted as inferred with 
BactDating (v.1.0)63 to maximize the posterior probability of the tree. 
Treedater (v.0.5)66 was also applied for the same purpose and found to 
give similar estimates for the dating of nodes (Supplementary Figs. 6–11 
and Source Data of Fig. 3).
The phylogenetic relationships between the type XI SCCmec ele-
ments were investigated in a separate analysis. A SNP alignment was 
generated from precalled SNPs from the 991 mecC-MRSA isolates. SNPs 
located outside the type XI SCCmec element (corresponding to nucleo-
tide positions 34,403 through 63,839 in mecC-MRSA CC425 isolate 
LGA251) were manually removed, and the remaining SNPs were used to 
construct an unrooted maximum-likelihood phylogenetic tree using 
PhyML (v.3.0)60,61 under the HKY85 substitution model after applying 
NNI moves to improve the BIONJ starting tree. Putative recombinogenic 
regions were detected and a recombination-corrected phylogeny was 
built using ClonalFrameML (v.1.12)62. The tips were manually mapped 
onto the CC130, CC425 and CC1943 phylogenies, and vice versa, to 
identify monophyletic mecC-MRSA lineages harbouring orthologous 
type XI SCCmec elements.
Genome sequencing and analysis of the T. erinacei type strain 
IMI 101051
DNA extracted from the T. erinacei type strain IMI 101051 was used to 
prepare a DNA library in accordance with the Nextera XT DNA Library 
Prep Guide (Illumina) and sequenced on a MiSeq platform (Illumina) 
with 2 × 251 bp using a MiSeq Reagent Kit v2 (Illumina). Short-read 
sequencing data were submitted to the European Nucleotide Archive 
under BioProject PRJEB43453. A draft genome was de novo assembled 
using SPAdes (v.3.15)46. We used the translated protein sequences of the 
P. chrysogenum pcbAB, pcbC and penDE genes and the A. chrysogenum 
cefD1, cefD2, cefEF and cefG genes (Extended Data Table 1) as queries in 
TBLASTN searches against the draft genome. Hits were used as queries 
in BLASTP searches against the UniProtKB/Swiss-Prot protein database. 
Bidirectional best hits with a TBLASTN and BLASTP value of less than 
1 × 10−100 in both directions were considered as orthologous gene pairs.
In vitro antibiotic production by the T. erinacei type strain IMI 
101051
In vitro antibiotic production by the T. erinacei type strain IMI 101051 
was determined using a method modified from Smith and Marples15. 
In brief, the strain was grown on a Sabouraud dextrose agar plate 
(Oxoid) for 7 days at 30 °C. The culture was removed using distilled 
water and a 100-µl suspension was placed in 5 ml Sabouraud dextrose 
broth (SDB) (Sigma-Aldrich) followed by incubation at 30 °C with shak-
ing at 200 rpm for 3 days. The culture was placed on a Miracloth mesh 
(Calbiochem) in a 13-cm petri dish containing 35 ml SDB. The plate 
was incubated at 30 °C for 7 days, after which the mesh containing the 
fungal mass was placed in a 2-l conical flask containing 75 ml SDB sup-
plemented with 2% glucose. The flask was incubated at 30 °C with shak-
ing at 200 rpm for 7 days. The broth was replaced with fresh 5-strength 
SDB, and the flask was incubated at 30 °C for another 6 days. The culture 
medium was transferred into two 50-ml Falcon tubes containing 3 ml 
Diaion HP-20 resin (Supelco) slurried in 3 ml distilled water. The tubes 
were placed on a rotator for 1 h, after which the beads were allowed 
to settle. The supernatant was discarded and antibiotics were eluted 
from the resin with 9 ml acetone. The eluate was placed on a rotator 
for 30 min and centrifuged briefly to pellet the resin. The supernatant 
was transferred to 2-ml Eppendorf tubes, which were placed in a rotary 
evaporator at 30 °C. This process was repeated until all of the eluate had 
evaporated to dryness. To prepare bacterial inocula, S. aureus strains 
were individually grown overnight on blood agar plates (Oxoid) at 37 °C. 
Colonies were suspended in phosphate-buffered saline (PBS) to a 0.5 
McFarland standard, diluted 1:10 in PBS, and streaked evenly on the 
surface of a Iso-Sensitest agar plate (Oxoid) using a sterile cotton-wool 
swab. Dried fungal culture extracts were suspended in 200 µl distilled 
water. Sterile paper discs were impregnated with 10 µl solution and 
placed on the agar plates. In vitro antibiotic production was assessed 
by measuring the inhibition zones after overnight incubation at 35 °C.
Metabolic profiling by LC–MS
Dried fungal culture extracts were suspended in 50% methanol to a con-
centration of 100 mg ml−1, diluted 1:10 in pure methanol and analysed 
using LC–MS. Metabolic profiles were obtained on a Vanquish UHPLC 
system (Thermo Fisher Scientific) coupled to a Vanquish diode array 
detector (Thermo Fisher Scientific) and an Orbitrap Fusion Tribrid 
high-resolution tandem mass spectrometer (Thermo Fisher Scien-
tific). Chromatographic separation of 5 µl fungal culture extracts was 
performed on a Luna C18 column (3 µm, 3 × 150 mm) (Phenomenex) 
using a linear mobile phase gradient from 0% methanol, 90% water 
and 10% acetonitrile containing 1% (v/v) formic acid to 90% methanol, 
0% water and 10% acetonitrile containing 1% (v/v) formic acid over 
20 min at a flow rate of 400 µl min−1. Ultraviolet data were recorded 
between 210 nm and 550 nm. For comparative purposes, a pure stand-
ard of penicillin G (Sigma-Aldrich) was prepared at a final concentration 
of 9.4 µg ml−1 and analysed using LC–MS.
Mass spectra were obtained in the positive and negative ionization 
modes using the full scan and data-dependent MS2 and MS3 acquisi-
tion modes. Full scan total ion current chromatograms were obtained 
over the range of 125–1,800 m/z using a spray voltage of +3.5 kV and 
−2.5 kV for the positive and negative ionization modes, respectively. 
Three different scan events were recorded for the data-dependent 
acquisition modes as follows: (1) MS2 of the most intense ion in the 
full scan acquisition mode; (2) MS3 of the most intense ion in the MS2 
spectra; and (3) MS3 of the second-most intense ion in the MS2 spectra. 
Additional parameters for the MS included the following: full scan 
resolution set to 60,000 (full-width at half-maximum, FWHM), capil-
lary temperature set to 350 °C, ion transfer tube temperature set to 
325 °C, RF lens set to 50%, automatic gain control target set to 4.0 × 105 
(full scan) or 1.0 × 104 (MS2 and MS3), intensity threshold set to 1.0 × 104, 
collision-induced dissociation energy set to 35 eV, activation Q set to 
0.25 and isolation window set to 4 m/z. Nitrogen was used as the drying, 
nebulizer and fragmentation gas.
Molecular networking analysis of LC–MS data
A molecular network was created using the Global Natural Products 
Social Molecular Networking (GNPS) workflow67. Chromatographic raw 
data in the positive ionization mode were transformed to the mzXML 
format using the ProteoWizard command-line utility msConvert68. 
The data were then filtered by removing all MS2 fragment ions within 
±17 Da of the precursor m/z value. The precursor ion mass and MS2 
fragment ion tolerances were set to 2.0 Da and 0.5 Da, respectively, 
to enable more comprehensive comparisons with the GNPS database. 
MS2 spectra were filtered by choosing the top six fragment ions in the 
±50-Da window throughout the spectrum. A network was then cre-
ated considering a cosine score above 0.7 and more than six matched 
peaks to link different nodes through edges. Edges between two nodes 
were kept in the network if each of the nodes appeared in each other’s 
respective top ten most similar nodes. Finally, the maximum size of a 
molecular family was set to 100. The spectra in the network were then 
searched against spectral libraries in GNPS, filtering the library spectra 
in the same manner as the input data. All matches between network 
spectra and library spectra were required to have a score above 0.7 
and at least six matched peaks.
Statistics
Statistical analyses were performed using GraphPad Prism (v.8.3) 
(GraphPad Software). We used two-tailed paired Student’s t-tests 
to compare inhibition zones of each mutant to the corresponding 
mecC-MRSA wild-type strain and a two-tailed Wilcoxon matched-pairs 
signed rank test to compare population structures of mecC-MRSA at 
the lineage level.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
LC–MS data in mzXML format and molecular networking results are 
available at the MassIVE repository under identifier MSV000087335. 
S. aureus short-read sequence data have been deposited in the Euro-
pean Nucleotide Archive/NCBI Sequence Read Archive under BioPro-
ject IDs PRJEB15105, PRJEB21015, PRJEB2655, PRJEB2755, PRJEB2756, 
PRJEB28206, PRJEB3174, PRJEB32898, PRJNA596428 and PRJEB43456 
and the genome accession numbers are provided in Supplementary 
Table 1. T. erinacei type strain IMI 101051 short-read sequence data have 
been deposited in the European Nucleotide Archive under BioProject 
PRJEB43453. Tree and genealogy files in Newick format are provided 
in Supplementary Data 1–10. Source data are provided with this paper.
 
46. Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its application to 
single-cell sequencing. J. Comput. Biol. 19, 455–477 (2012).
47. Enright, M. C., Day, N. P., Davies, C. E., Peacock, S. J., Spratt, B. G. Multilocus sequence 
typing for characterization of methicillin-resistant and methicillin-susceptible clones of 
Staphylococcus aureus. J. Clin. Microbiol. 38, 1008–1015 (2000).
Article
48. Van Wamel, W. J., Rooijakkers, S. H., Ruyken, M. van Kessel, K. P. & Strijp, J. A. The innate 
immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory 
protein of Staphylococcus aureus are located on beta-hemolysin-converting 
bacteriophages. J. Bacteriol. 188, 1310–1315 (2006).
49. Viana, D. et al. Adaptation of Staphylococcus aureus to ruminant and equine hosts 
involved SaPI-carried variants of von Willebrand factor-binding protein. Mol. Microbiol. 
77, 1583–1594 (2010).
50. Rooijakkers, S. H. M. et al. Staphylococcal complement inhibitor: structure and active 
sites. J. Immunol. 179, 2989–2998 (2007).
51. Arndt, D. et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic 
Acids Res. 44, W16–W21 (2016).
52. Bortolaia, V. et al. ResFinder 4.0 for predictions of phenotypes from genotypes.  
J. Antimicrob. Chemother. 75, 3491–3500 (2020).
53. Clausen, P. T. L. C., Aarestrup, F. M. & Lund, O. Rapid and precise alignment of raw reads 
against redundant database with KMA. BMC Bioinform. 19, 397 (2018).
54. Sahl, J. W. et al. NASP: an accurate, rapid method for the identification of SNPs in WGS 
datasets that supports flexible input and output formats. Microb. Genom. 2, e000074 
(2016).
55. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrow-Wheeler transform. 
Bioinformatics 25, 1754–1760 (2009).
56. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing 
next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
57. DePristo, M. A. et al. A framework for variation discovery and genotyping using 
next-generation sequencing data. Nat. Genet. 43, 491–498 (2011).
58. Delcher, A. L., Phillippy, A., Carlton, J. & Salzberg, S. L. Fast algorithms for large-scale 
genome alignment and comparison. Nucleic Acids Res. 30, 2478–2483 (2002).
59. Kurz, S. et al. Versatile and open software for comparing large genomes. Genome Biol. 5, 
R12 (2004).
60. Guindon, S. & Gasquel, O. A simple, fast, and accurate algorithm to estimate large 
phylogenies by maximum likelihood. Syst. Biol. 52, 696–704 (2003).
61. Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood 
phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59, 307–321  
(2010).
62. Didelot, X. & Wilson, D. J. ClonalFrameML: efficient inference of recombination in whole 
bacterial genome. PLoS Comput. Biol. 11, e1004041 (2015).
63. Didelot, X. et al. Bayesian inference of ancestral dates on bacterial phylogenetic trees. 
Nucleic Acids Res. 46, e134 (2018).
64. Didelot, X., Siveroni, I. & Volz, E. M. Additive uncorrelated relaxed clock models for  
the dating of genomic epidemiology phylogenies. Mol. Biol. Evol. 38, 307–317  
(2021).
65. Plummer, M., Best, N., Cowles, K. & Vines, K. CODA: convergence diagnosis and output 
analysis for MCMC. R News 6, 7–11 (2006).
66. Volz, E. M. & Frost, S. D. Scalable relaxed clock phylogenetic dating. Virus Evol. 3, vex025 
(2017).
67. Wang, M. et al. Sharing and community curation of mass spectrometry data with  
Global Natural Products Social Molecular Networking. Nat. Biotechnol. 34, 828–837 
(2016).
68. Adusumilli, R. & Mallick, P. Data conversion with ProteoWizard msConvert. Methods Mol. 
Biol. 1550, 339–368 (2017).
Acknowledgements We thank M. Ganoti, F. Attila-Zoltán, M. Dugar, Z. Pokorná, D. Madsen,  
S. M. Gamborg, R. Molina-López, C. Rodrigues, T. Vieira, J. Viricel, A. Fingar, K. South, G. Prince, 
H. Gasser, S. Sebright, N. Ennew, C. Catchpole, E. Acton, N. Acton, K. Horrey and P. Loague for 
providing hedgehog samples; A. Medina, L. R. H. Kildevang, P. T. Hansen, and S. M. Johansson 
for technical assistance during the analysis of hedgehog samples; A. E. Henius for help with 
Figs. 1, 4 and Extended Data Fig. 8; and V. Bortolaia for reading the manuscript. This work is 
dedicated to V. R. Simpson, who passed away during the study. B.Č.B. was supported by a 
grant from the Czech University of Life Sciences Prague (no. IGA 20213106). X.D. was funded 
by a grant from the National Institute for Health Research (NIHR) Health Protection Research 
Unit in Genomics and Enabling Data (no. NIHR200892). M.A.H. was supported by grants from 
the Medical Research Council (nos. G1001787/1, MR/N002660/1 and MR/P007201/1) and the 
Economic and Social Research Council (no. ES/S000186/1). E.M.H. was supported by a UK 
Research and Innovation (UKRI) Fellowship (no. MR/S00291X/1). We acknowledge Eurostat for 
the provision of maps, which are licensed under the Creative Commons Attribution 4.0 
International (CC BY 4.0) licence, and administrative boundaries, which are copyright of 
EuroGeographics.
Author contributions J.L., M.A.H., E.M.H. and A.R.L. initiated and designed the study. J.L., 
C.L.R., B.Č.B., P.H. and S.L.R. directed the hedgehog survey. J.L., C.L.R. X.B. and Ø.A. analysed 
hedgehog samples. C.L.R., I.L., H.K., P.A., R.H., A.D., S.V., R.L.S., A.P., C.E.-G., F.M.A., L.J.L., 
S.M.N., F. Laurent, K.B., B.W., C.K., C.C., F. Layer, G.W., W.W., I.S., P.M., H.J.J., H.d.L., E.C., F.G.-G., 
S.B., S.H., V.P., C.J.T., A.S.W., B.P., M.D.C., M.J.E., S.J.P., D.J.S., N.F.H., J.A.L., G.F.E., G.F., G.K.P., 
M.A.H. and A.R.L. provided bacterial isolates from other sources. X.B., C.B., M.S., F.J.E.M., G.K.P. 
and M.A.H. conducted whole-genome sequencing of bacterial isolates. J.L., C.L.R., R.N.S., 
J.J.W., J.P., M.T.G.H., X.D., M.A.H. and E.M.H. performed sequence and phylogenetic analyses of 
bacterial isolates. J.L., M.C.A. and R.K.H. performed genome sequencing and analysis of  
T. erinacei IMI 101051. C.L.R., X.B. and D.J.S. investigated in vitro antibiotic production by  
T. erinacei IMI 101051. N.J.S. prepared samples, performed LC–MS analysis and guided the 
identification of the penicillin-like substances. G.F.P.-G. analysed LC–MS data, performed 
molecular networking analysis and identified the two penicillin-like substances. M.S.J.S. 
coordinated and supervised the LC–MS analysis. J.L. wrote the manuscript with considerable 
input from C.L.R., X.B., N.J.S., G.F.P.-G., X.D., M.A.H., E.M.H. and A.R.L. All of the authors 
reviewed the manuscript.
Competing interests The authors declare no competing interests.
Additional information
Supplementary information The online version contains supplementary material available at 
https://doi.org/10.1038/s41586-021-04265-w.
Correspondence and requests for materials should be addressed to Jesper Larsen.
Peer review information Nature thanks Ross Fitzgerald and the other, anonymous, reviewer(s) 
for their contribution to the peer review of this work.
Reprints and permissions information is available at http://www.nature.com/reprints.
Extended Data Fig. 1 | Distribution of mecC-MRSA clones in European and 
New Zealand hedgehogs. The analysis included 828 samples from the nasal 
area, skin and feet of 276 hedgehogs originating from 16 wildlife rescue centres 
in ten European countries and two wildlife rescue centres in New Zealand.  
a, Presence of mecC-MRSA in hedgehogs (n = 276). Presence and absence are 
shown as black and white boxes, respectively. b, Distribution of mecC-MRSA 
clones in hedgehog samples (n = 828). c, Distribution of MSSA clones in 

















































































Extended Data Fig. 2 | Detection of penicillin G in T. erinacei IMI 
101051 culture broth. a, Left and right panels show extracted ion 
chromatogram of a pure standard of penicillin G and in T. erinacei culture 
broth, respectively. b, Upper and lower panels show MS2 spectra of penicillin G 


















































































Extended Data Fig. 3 | Detection of KPN in T. erinacei IMI 101051 culture 
broth. a, Left and right panels show extracted ion chromatogram of a pure 
standard of penicillin G and KPN in T. erinacei culture broth, respectively.  
b, Upper and lower panels show MS2 spectra of KPN in a T. erinacei culture broth 
and a pure standard of penicillin G, respectively.
Article
Extended Data Fig. 4 | Antibiotic activity of T. erinacei IMI 101051. T. erinacei 
inhibition zones against a collection of S. aureus control strains and two 
mecC-MRSA wild-type strains belonging to CC130 (02.5099.D) and CC425 
(LGA251) and their isogenic mutants. The numbers on the plates refer to each 
of four biologically independent fungal culture extracts.
Extended Data Fig. 5 | Root-to-tip linear regression analysis of the type XI 
SCCmec dataset. The correlation between root-to-tip distances and isolation 
dates is very weak with a coefficient of determination R2 = −0.05.
Article
Extended Data Fig. 6 | Number of mecC-MRSA CC1943 sublineages. The bars 
show the number of sublineages of mecC-MRSA CC1943:C1, mecC-MRSA 
CC1943:C2 and mecC-MRSA CC1943:C3 at different time points.
Extended Data Fig. 7 | Geographical distribution and host range of major 
mecC-MRSA CC130, CC425 and CC1943 lineages. The study collection 
included 991 mecC-MRSA CC130, CC425 and CC1943 isolates originating from 
16 European countries. The countries of sampling and the eight largest (≥25 
isolates) mecC-MRSA lineages are shown. Isolates belonging to the eight minor 
mecC-MRSA lineages are grouped together (others). The pie charts depict the 
proportion of mecC-MRSA isolates from hedgehogs (black), humans (grey) and 
other sources (white). The area of the pie chart is proportional to the number of 
mecC-MRSA isolates from that country.
Article
Extended Data Fig. 8 | Sampling locations of Danish mecC-MRSA isolates 
from hedgehogs and humans. The maps of Denmark relate to the map shown 
in Fig. 4. a, mecC-MRSA recovered from hedgehogs (n = 141). b, mecC-MRSA 
recovered from humans (n = 327). The location of each sample is given at the zip 
code area level. Maps were provided by Eurostat under a Creative Commons 
Attribution 4.0 International (CC BY 4.0) licence; the administrative 
boundaries are copyright of EuroGeographics.
Extended Data Fig. 9 | Frequency of potential transmission events of 
mecC-MRSA CC130 isolates within wildlife rescue centres. The bars show the 
proportion of isolates that belong to clusters defined at different pairwise SNP 
distance thresholds.
Article
Extended Data Table 1 | Penicillin biosynthetic genes in T. erinacei IMI 101051
*The in silico identified putative T. erinacei penicillin G and cephalosporin C biosynthetic genes are shown in green
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